Bellevue Capital Surpluse from 2010 to 2025

BBH Stock   125.00  1.40  1.11%   
Bellevue Healthcare's Capital Surpluse is increasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 305 M. During the period from 2010 to 2025 Bellevue Healthcare Capital Surpluse annual values regression line had geometric mean of  230,838,475 and mean square error of 7004.2 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
502.8 M
Current Value
305 M
Quarterly Volatility
155.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bellevue Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bellevue Healthcare's main balance sheet or income statement drivers, such as Tax Provision of 96.6 K, Net Interest Income of 438.5 K or Interest Income of 2.7 M, as well as many indicators such as . Bellevue financial statements analysis is a perfect complement when working with Bellevue Healthcare Valuation or Volatility modules.
  
This module can also supplement various Bellevue Healthcare Technical models . Check out the analysis of Bellevue Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Bellevue Stock

Bellevue Healthcare financial ratios help investors to determine whether Bellevue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bellevue with respect to the benefits of owning Bellevue Healthcare security.